Minor
Mutant CALR-peptide Based Vaccine · Mutated CALR Myeloproliferative Neoplasm
Enrollment closed, study ongoing
Also in this update: Final enrollment: 7 participants (planned 10)
Marina KremyanskayaPhase 1 NCT05025488 Registry history of NCT05025488 on ClinicalTrials.gov (opens the registry)
Updated